BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhong C, Qu C, Wang B, Liang S, Zeng B. Probiotics for Preventing and Treating Small Intestinal Bacterial Overgrowth: A Meta-Analysis and Systematic Review of Current Evidence. J Clin Gastroenterol 2017;51:300-11. [PMID: 28267052 DOI: 10.1097/MCG.0000000000000814] [Cited by in Crossref: 43] [Cited by in F6Publishing: 16] [Article Influence: 8.6] [Reference Citation Analysis]
Number Citing Articles
1 Liu Y, Tran DQ, Rhoads JM. Probiotics in Disease Prevention and Treatment. J Clin Pharmacol 2018;58 Suppl 10:S164-79. [PMID: 30248200 DOI: 10.1002/jcph.1121] [Cited by in Crossref: 39] [Cited by in F6Publishing: 30] [Article Influence: 13.0] [Reference Citation Analysis]
2 Hartmann P, Schnabl B. New Developments in Microbiome in Alcohol-Associated and Nonalcoholic Fatty Liver Disease. Semin Liver Dis 2021;41:87-102. [PMID: 33957682 DOI: 10.1055/s-0040-1719174] [Reference Citation Analysis]
3 Luquez-Mindiola A, Atuesta AJ, Gómez-Aldana AJ. Gastrointestinal manifestations of systemic sclerosis: An updated review. World J Clin Cases 2021; 9(22): 6201-6217 [PMID: 34434988 DOI: 10.12998/wjcc.v9.i22.6201] [Reference Citation Analysis]
4 Olas B. Probiotics, Prebiotics and Synbiotics-A Promising Strategy in Prevention and Treatment of Cardiovascular Diseases? Int J Mol Sci 2020;21:E9737. [PMID: 33419368 DOI: 10.3390/ijms21249737] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
5 Taverniti V, Cesari V, Gargari G, Rossi U, Biddau C, Lecchi C, Fiore W, Arioli S, Toschi I, Guglielmetti S. Probiotics Modulate Mouse Gut Microbiota and Influence Intestinal Immune and Serotonergic Gene Expression in a Site-Specific Fashion. Front Microbiol 2021;12:706135. [PMID: 34539604 DOI: 10.3389/fmicb.2021.706135] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Thoreau B, Chaigne B, Renaud A, Mouthon L. Treatment of systemic sclerosis. Presse Med 2021;50:104088. [PMID: 34718109 DOI: 10.1016/j.lpm.2021.104088] [Reference Citation Analysis]
7 Quigley EMM. The Spectrum of Small Intestinal Bacterial Overgrowth (SIBO). Curr Gastroenterol Rep. 2019;21:3. [PMID: 30645678 DOI: 10.1007/s11894-019-0671-z] [Cited by in Crossref: 39] [Cited by in F6Publishing: 34] [Article Influence: 13.0] [Reference Citation Analysis]
8 Jin XF, Spampatti MP, Spitzweg C, Auernhammer CJ. Supportive therapy in gastroenteropancreatic neuroendocrine tumors: Often forgotten but important. Rev Endocr Metab Disord 2018;19:145-58. [PMID: 29464446 DOI: 10.1007/s11154-018-9443-6] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 3.7] [Reference Citation Analysis]
9 L M L, L P B, S G G, L O S, O M D, R V B, L M S, M Ya S. Assessment of the Safety of Lactobacillus casei IMV B-7280 Probiotic Strain on a Mouse Model. Probiotics Antimicrob Proteins 2021. [PMID: 33876388 DOI: 10.1007/s12602-021-09789-1] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Judkins TC, Archer DL, Kramer DC, Solch RJ. Probiotics, Nutrition, and the Small Intestine. Curr Gastroenterol Rep 2020;22:2. [PMID: 31930437 DOI: 10.1007/s11894-019-0740-3] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
11 Bouchoucha M, Fysekidis M, Lekhal C, Bejou BD, Sabate JM, Benamouzig R. COLIGENTA treatment of small intestinal bacterial overgrowth. Results of an open study. Dig Liver Dis 2021;53:66-71. [PMID: 33229276 DOI: 10.1016/j.dld.2020.10.032] [Reference Citation Analysis]
12 Lazarenko L, Bubnov R, Babenko L, Melnykova O, Spivak M. Methodical approaches of estimation of probiotics` quality and rational principles of their usage in clinical practice. ScienceRise: Biological Science 2020;0:25-30. [DOI: 10.15587/2519-8025.2020.202216] [Reference Citation Analysis]
13 Sadgrove NJ, Padilla-González GF, Leuner O, Melnikovova I, Fernandez-Cusimamani E. Pharmacology of Natural Volatiles and Essential Oils in Food, Therapy, and Disease Prophylaxis. Front Pharmacol 2021;12:740302. [PMID: 34744723 DOI: 10.3389/fphar.2021.740302] [Reference Citation Analysis]
14 Lee SH, Joo NS, Kim KM, Kim KN. The Therapeutic Effect of a Multistrain Probiotic on Diarrhea-Predominant Irritable Bowel Syndrome: A Pilot Study. Gastroenterol Res Pract 2018;2018:8791916. [PMID: 30622561 DOI: 10.1155/2018/8791916] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
15 Brown BI. Does Irritable Bowel Syndrome Exist? Identifiable and Treatable Causes of Associated Symptoms Suggest It May Not. GastrointestDisord 2019;1:314-40. [DOI: 10.3390/gidisord1030027] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
16 Frech TM, Mar D. Gastrointestinal and Hepatic Disease in Systemic Sclerosis. Rheum Dis Clin North Am. 2018;44:15-28. [PMID: 29149923 DOI: 10.1016/j.rdc.2017.09.002] [Cited by in Crossref: 20] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
17 Xu F, Li N, Wang C, Xing H, Chen D, Wei Y. Clinical efficacy of fecal microbiota transplantation for patients with small intestinal bacterial overgrowth: a randomized, placebo-controlled clinic study. BMC Gastroenterol 2021;21:54. [PMID: 33549047 DOI: 10.1186/s12876-021-01630-x] [Reference Citation Analysis]
18 Singh R, Zogg H, Wei L, Bartlett A, Ghoshal UC, Rajender S, Ro S. Gut Microbial Dysbiosis in the Pathogenesis of Gastrointestinal Dysmotility and Metabolic Disorders.J Neurogastroenterol Motil. 2021;27:19-34. [PMID: 33166939 DOI: 10.5056/jnm20149] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 9.0] [Reference Citation Analysis]
19 Kuang L, Zhou W, Jiang Y. Association of small intestinal bacterial overgrowth with nonalcoholic fatty liver disease in children: A meta-analysis. PLoS One 2021;16:e0260479. [PMID: 34855819 DOI: 10.1371/journal.pone.0260479] [Reference Citation Analysis]
20 Wendel D, Ho BE, Kaenkumchorn T, Horslen SP. Advances in non-surgical treatment for pediatric patients with short bowel syndrome. Expert Opinion on Orphan Drugs 2020;8:157-68. [DOI: 10.1080/21678707.2020.1770079] [Reference Citation Analysis]
21 Rao SSC, Bhagatwala J. Small Intestinal Bacterial Overgrowth: Clinical Features and Therapeutic Management. Clin Transl Gastroenterol. 2019;10:e00078. [PMID: 31584459 DOI: 10.14309/ctg.0000000000000078] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 11.5] [Reference Citation Analysis]
22 Sattar B, Chokshi RV. Colonic and Anorectal Manifestations of Systemic Sclerosis. Curr Gastroenterol Rep. 2019;21:33. [PMID: 31281951 DOI: 10.1007/s11894-019-0699-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]